NCT06781762View on ClinicalTrials.gov

Short-term Impacts of Endocrine Therapy on Cardiovascular and Brain Health Outcomes in Breast Cancer

RecruitingOBSERVATIONAL

Enrollment

40

Participants

Timeline

Start Date

June 6, 2025

Primary Completion Date

December 30, 2026

Study Completion Date

December 30, 2026

Conditions

Breast Cancer Females

Interventions

OTHER

N/A (Usual Care)

BC survivors will be using aromatase inhibitors as prescribed in their usual care treatment.

Trial Locations (1)

M5S2C9

RECRUITING

University of Toronto, Toronto

Sponsors

Collaborators (1)

Cancer Research Society

All Listed Sponsors

collaborator

Cancer Research Society

OTHER

collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

collaborator

Princess Margaret Hospital, Canada

OTHER

lead

University of Toronto

OTHER